News
Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans
1+ mon, 1+ week ago (567+ words) Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans'BioSpace Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans - Program offers significant savings on over 30 brands spanning women's health, migraine, arthritis,…...
TrumpRx Delayed Amid Potential Anti-Kickback Concerns
1+ mon, 2+ week ago (369+ words) Flickr, White House/Daniel Torok The White House has delayed the launch of TrumpRx, the federal government's proposed marketplace that will allow patients to purchase their medicines directly from pharma companies. "In any other administration, it would 100 percent be the…...
Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech
2+ mon, 3+ day ago (771+ words) Acadia CEO Catherine Owen Adams, After a year of watching major pharma companies in the Trump administration's hot seat for drug pricing, Acadia Pharmaceuticals CEO Catherine Owen Adams isn't taking any chances. The CEO is one of the founders of…...
Trump Takes Drug Pricing Fight To Insurers With ‘The Great Healthcare Plan’
2+ mon, 1+ day ago (468+ words) President Donald Trump unveiled "The Great Healthcare Plan" on Thursday, calling on Congress to enact changes to lower drug prices and insurance premiums and stretch Most Favored Nation drug pricing beyond the 17 pharma companies that were targeted last year. Speaking…...
Vizient Analysis Reveals Early and Varied Drug Pricing Shifts Following Enactment of the Inflation Reduction Act
2+ mon, 1+ week ago (164+ words) The analysis reviewed wholesale acquisition cost (WAC) trends across the top-spend Medicare drugs. While multiple provisions of the IRA have not yet been implemented and market dynamics also influence manufacturer decisions, early observations of the IRA's potential effects on medication…...
Pfizer Leads Industry-Wide Surge in Drug Prices for 2026 Despite Political Pressure
2+ mon, 2+ week ago (248+ words) Drugmakers plan to raise the U.S. prices of 40% more drugs in 2026 than they did in 2025despite pressure from President Donald Trump to charge less. Specifically, more than a dozen Big Pharmas have now reached Most Favored Nation agreements with the White House....
How Effective Will TrumpRx and Other Direct-to-Consumer Drug Pricing Initiatives Be?
4+ mon, 5+ day ago (1731+ words) President Donald Trump has made lowering drug prices a cornerstone of his domestic policy agenda, the core of which is his Most Favored Nation (MFN) scheme, which seeks to force U.S. drug prices down to the same level as in similarly…...
Generic Drug and API Manufacturers Call for Onshoring Incentives
4+ mon, 1+ week ago (464+ words) Anas" proposed fix for the problem goes beyond the scope of PreCheck, which is aimed at making it easier for companies to build new facilities in the U.S., or indeed beyond the FDA"s powers. Citing Congress" push to promote domestic…...
In Affordability Push, EMD Serono Joins TrumpRx While Roche Launches DTC Program
5+ mon, 1+ hour ago (243+ words) Roche and EMD Serono are joining the industry-wide push to lower healthcare costs in the U.S., falling in line with the Trump administration's agenda. EMD Serono, the U.S. healthcare unit of German pharma giant Merck KGaA, has pledged to participate in the…...
AstraZeneca Becomes Second Pharma to Strike DTC Deal With Trump Administration
5+ mon, 6+ day ago (292+ words) BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. The British pharmaceutical giant has…...